Calumet, Inc.

CLMT Basic Materials Specialty Chemicals

Calumet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.1 billion, down 1.25% from fiscal 2024. In the quarter to June 2026, revenue grew 40.8%, EPS grew 35.9%, free cash flow grew 450.7% and total debt fell 1.98%, each against the same quarter a year earlier. Dividend growth for five consecutive years.

57.75 0.49 −0.84%
Market cap
$5.1B
P/E
0.0×
Fwd P/E
−9.0×
Dividend yield
—
F-score
5/9
Altman Z
1.16
Beneish M
−2.96
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
3 6 5 6 3 3 6 4 2 5
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 26.08 0.00 0.00
Altman Z-Score
— — — — — — — — 1.02 1.16
P/S ratio
0.09 0.15 0.05 0.08 0.11 0.33 0.28 0.34 0.44 0.42
P/FCF ratio
0.00 0.00 6.68 2.03 12.98 0.00 0.00 0.00 0.00 30.46
Altman Z″-Score (non-manufacturers)
— — — — — — — — (2.25) (1.82)
Beneish M-Score
(3.05) (2.10) (3.04) (3.03) (2.06) (2.42) (3.01) (2.48) (2.22) (2.96)
P/Operating CF
13.46 (24.58) 1.65 7.51 (116.81) (73.94) (25.89) (187.38) (538.50) 14.80
P/B ratio
1.52 5.38 3.26 29.74 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
0.66 0.54 0.46 0.43 0.70 0.86 0.70 0.85 0.99 0.95
EV/EBITDA
12.45 6.08 6.39 7.18 0.00 0.00 25.00 13.32 509.96 19.30
EV/Operating CF
561.26 (77.30) 21.56 7.70 25.28 (61.58) 32.78 (238.93) (89.02) 36.01
EV/FCF
(17.25) (21.29) 62.83 10.50 84.00 (61.72) (7.57) (12.42) (33.55) 69.29
Quick Ratio
0.42 0.94 0.85 0.37 0.50 0.32 0.22 0.26 0.38 0.52
Current Ratio
1.29 1.29 1.61 0.91 0.98 0.70 0.61 0.71 0.89 1.02
Net Debt/EBITDA
10.78 4.38 5.71 5.80 28.08 42.63 7.90 4.79 11.79 7.36
Debt/Assets
73.29% 74.10% 76.86% 65.20% 80.28% 80.13% 74.28% 78.61% 85.04% 89.36%
Debt/Equity
9.13 16.62 24.42 56.08 (11.29) (4.43) (3.82) (4.41) (3.29) (3.28)
Asset Turnover
1.23 1.39 1.46 1.75 1.24 1.60 1.93 1.52 1.52 1.52
Operating CF/Net income
(0.01) 0.26 (1.39) (4.49) (0.43) 0.17 (0.59) (0.32) 0.21 (3.22)
Capex/Depreciation
(0.74) (0.39) (0.38) (0.40) (0.37) 0.00 (4.42) (1.49) (0.41) (0.28)
Interest Coverage
0.00 0.86 0.79 0.57 (0.57) (0.57) 0.75 1.21 0.03 0.50
ROE
(82.64%) (65.83%) (67.92%) (136.64%) 228.13% 96.83% 36.81% (9.19%) 36.89% 4.68%
ROA
(11.36%) (3.76%) (2.26%) (2.16%) (7.96%) (12.95%) (6.97%) 1.72% (8.06%) (1.24%)
ROIC
(0.01%) 6.18% 5.07% 3.93% (3.70%) (4.17%) 5.62% 10.03% 0.32% 4.64%
Return on Tangible Assets
(18.14%) (7.14%) (3.99%) (4.64%) (16.04%) (37.35%) (17.86%) 3.96% (16.55%) (2.47%)
Average Days of Receivables
21.53 34.34 20.66 19.93 25.81 29.33 20.80 24.99 24.23 20.51
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
5.05% 5.43% 5.17% 5.50% 6.12% 6.48% 4.21% 4.49% 4.80% 4.15%
Intangible Assets out of Total Assets
0.11 0.10 0.12 0.13 0.13 0.10 0.08 0.07 0.07 0.06
Share Based Compensation of Revenue
0.16% 0.31% (0.03%) 0.17% 0.24% 1.61% 0.37% 0.35% 0.35% (0.11%)
Graham Net Nets
(6.05) (2.41) (7.85) (4.64) (5.72) (1.80) (1.89) (1.74) (1.48) (1.49)
Graham Number
0.00 0.00 0.00 0.00 8.57 18.92 17.57 0.00 22.55 8.61
Earnings Yield
(104.75%) (14.69%) (31.22%) (15.07%) (59.42%) (24.47%) (12.48%) 3.83% (11.99%) (1.96%)
Free Cash Flow Yield
(43.29%) (16.87%) 14.98% 49.29% 7.70% (4.21%) (33.57%) (20.40%) (6.72%) 3.28%
Revenue per Share
45.10 48.50 44.87 44.14 28.94 39.86 59.07 52.21 50.39 47.68
Operating CF per Share
0.05 (0.34) 0.96 2.45 0.80 (0.56) 1.27 (0.19) (0.56) 1.26
Capex per Share
(1.78) (0.90) (0.63) (0.65) (0.56) 0.00 (6.76) (3.39) (0.92) (0.60)
Free Cash Flow per Share
(1.73) (1.24) 0.33 1.80 0.24 (0.56) (5.49) (3.58) (1.48) 0.65
Cash per Share
0.05 6.63 2.00 0.24 1.40 0.48 0.44 0.10 0.55 2.36
Shareholders Equity per Share
2.84 1.55 0.84 0.28 (1.64) (4.88) (6.72) (6.12) (8.56) (8.44)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
2.84 1.55 0.84 0.28 (1.64) (4.88) (6.72) (6.12) (8.56) (8.44)
Free Cash Flow
(133.40) (96.20) 25.80 140.70 18.90 (43.90) (435.40) (286.70) (123.10) 56.60
Working Capital
142.70 265.80 254.90 (52.90) (9.60) (267.20) (531.30) (318.00) (97.60) 17.10
Capital Expenditures
(137.50) (69.70) (49.40) (51.20) (43.90) 0.10 (536.00) (271.80) (76.70) (52.30)
Net Current Asset Value
(1,865.60) (1,377.40) (1,351.80) (1,324.10) (1,402.00) (1,880.40) (2,454.70) (2,446.90) (2,704.10) (2,563.80)
EV/EBIT
0.00 12.96 13.19 19.37 0.00 0.00 25.00 13.32 509.97 36.08
Capex to Sales
0.04 0.02 0.01 0.01 0.02 0.00 0.11 0.07 0.02 0.01
Price to Operating Income
0.00 3.61 1.40 3.74 0.00 0.00 9.83 5.26 226.04 15.86
Other line items
Depreciation/Fixed assets
0.11 0.15 0.12 0.13 0.13 0.13 0.08 0.12 0.13 0.14
Cash ROIC
(6.01%) (3.66%) 1.41% 11.24% 1.32% (3.23%) (28.31%) (17.06%) (7.33%) 3.02%
Accounts Receivable Turnover
16.72 13.47 12.67 17.87 13.00 15.23 18.02 15.11 14.85 16.20
Accounts Payable Turnover
10.42 11.70 12.68 13.93 10.59 12.51 11.67 9.76 12.32 12.92
Inventory Turnover
8.32 9.72 10.23 10.41 7.92 10.34 10.52 7.96 9.25 9.71
Average Days of Payables
32.61 31.55 23.92 28.00 30.17 36.56 37.22 31.52 29.58 26.40
Days of Inventory on Hand
42.29 35.14 33.88 35.59 42.89 39.67 41.91 43.01 38.38 36.13
Average Receivables
207.80 279.50 276.05 193.25 174.45 206.70 260.05 276.65 282.15 255.30
Average Payables
296.25 279.10 241.45 215.40 204.75 240.15 371.50 382.00 321.40 301.15
Average Inventory
371.10 336.10 299.25 288.35 273.75 290.75 412.15 468.55 427.85 400.75
Average Assets
2,834.95 2,707.00 2,388.15 1,972.65 1,833.05 1,968.10 2,434.45 2,746.15 2,754.75 2,723.55
Average Common Equity
389.65 154.50 79.50 31.25 (64.00) (263.25) (461.25) (512.60) (601.75) (722.30)

Fold the line items

Columns are period end dates